Hatice Yücel

846 total citations · 1 hit paper
6 papers, 597 citations indexed

About

Hatice Yücel is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hatice Yücel has authored 6 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Hatice Yücel's work include DNA Repair Mechanisms (3 papers), PARP inhibition in cancer therapy (3 papers) and CRISPR and Genetic Engineering (2 papers). Hatice Yücel is often cited by papers focused on DNA Repair Mechanisms (3 papers), PARP inhibition in cancer therapy (3 papers) and CRISPR and Genetic Engineering (2 papers). Hatice Yücel collaborates with scholars based in Netherlands, Switzerland and France. Hatice Yücel's co-authors include Raphaël Ceccaldi, Alan D. D’Andrea, Jos Jonkers, Marieke van de Ven, Sven Rottenberg, Ewa Gogola, Beatrice Rondinelli, Panagiotis A. Konstantinopoulos, Alexandra A. Duarte and Camille Gelot and has published in prestigious journals such as Genes & Development, Molecular Cell and Nature Cell Biology.

In The Last Decade

Hatice Yücel

5 papers receiving 595 citations

Hit Papers

A first-in-class polymerase theta inhibitor selectively t... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hatice Yücel Netherlands 4 506 366 89 62 34 6 597
Benjamin Primack United States 5 654 1.3× 387 1.1× 97 1.1× 97 1.6× 28 0.8× 10 748
Ewa Gogola Netherlands 9 654 1.3× 544 1.5× 96 1.1× 98 1.6× 44 1.3× 11 812
Ute Boon Netherlands 4 603 1.2× 506 1.4× 178 2.0× 85 1.4× 57 1.7× 6 713
Niraj Joshi Canada 6 621 1.2× 271 0.7× 123 1.4× 100 1.6× 27 0.8× 7 695
Connor S. Clairmont United States 10 564 1.1× 277 0.8× 73 0.8× 76 1.2× 16 0.5× 13 626
Kate Sleeth United Kingdom 6 372 0.7× 265 0.7× 54 0.6× 68 1.1× 18 0.5× 9 440
Muthana Al Abo United States 10 365 0.7× 208 0.6× 36 0.4× 71 1.1× 15 0.4× 15 439
Kamakoti P. Bhat United States 7 937 1.9× 357 1.0× 96 1.1× 108 1.7× 18 0.5× 7 999
Camille Gelot France 8 442 0.9× 212 0.6× 44 0.5× 56 0.9× 16 0.5× 12 515
Tanay Thakar United States 9 355 0.7× 201 0.5× 45 0.5× 52 0.8× 18 0.5× 9 397

Countries citing papers authored by Hatice Yücel

Since Specialization
Citations

This map shows the geographic impact of Hatice Yücel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatice Yücel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatice Yücel more than expected).

Fields of papers citing papers by Hatice Yücel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hatice Yücel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatice Yücel. The network helps show where Hatice Yücel may publish in the future.

Co-authorship network of co-authors of Hatice Yücel

This figure shows the co-authorship network connecting the top 25 collaborators of Hatice Yücel. A scholar is included among the top collaborators of Hatice Yücel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hatice Yücel. Hatice Yücel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Musiani, Daniele, Hatice Yücel, Rania El Botty, et al.. (2025). Uracil processing by SMUG1 in the absence of UNG triggers homologous recombination and selectively kills BRCA1/2-deficient tumors. Molecular Cell. 85(6). 1072–1084.e10. 3 indexed citations
3.
Zhou, Jia, Camille Gelot, Constantia Pantelidou, et al.. (2021). A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors. Nature Cancer. 2(6). 598–610. 226 indexed citations breakdown →
4.
Rondinelli, Beatrice, Ewa Gogola, Hatice Yücel, et al.. (2017). EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation. Nature Cell Biology. 19(11). 1371–1378. 256 indexed citations
5.
Borst, Gerben R., Ramya Kumareswaran, Hatice Yücel, et al.. (2017). Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget. 8(50). 87638–87646. 12 indexed citations
6.
Annunziato, Stefano, Sjors M. Kas, Micha Nethe, et al.. (2016). Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland. Genes & Development. 30(12). 1470–1480. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026